השוואת שיטות
סקרו את השיטות שבחרתם זו לצד זו; שורות שבהן יש הבדל מודגשות.
| מדד PASI (Psoriasis Area and Severity Index)× | מדד SCORAD (SCORing Atopic Dermatitis)× | |
|---|---|---|
| תחום | דרמטולוגיה | דרמטולוגיה |
| משפחה | Process / pipeline | Process / pipeline |
| שנת המקור≠ | 1978 | 1993 |
| הוגה השיטה≠ | Fredriksson T, Pettersson U | European Task Force on Atopic Dermatitis (ETFAD) |
| סוג | Clinician-rated | Clinician-rated |
| מקור מכונן≠ | Fredriksson T, Pettersson U. Severe psoriasis—oral therapy with a new retinoid. Dermatologica. 1978;157(4):238-244. DOI ↗ | Kunz B, Oranje AP, Labrèze L, et al. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997;195(1):10-19. DOI ↗ |
| כינויים | PASI Index | SCORAD Index |
| קשורות≠ | 2 | 3 |
| תקציר≠ | The PASI is the gold-standard clinician-administered measure of psoriasis severity and extent. Developed by Fredriksson and Pettersson in 1978, it evaluates four cardinal clinical signs (erythema, induration, desquamation) across four body regions, each weighted by anatomical importance. PASI is the most widely used endpoint in psoriasis clinical trials and is endorsed by regulatory agencies (FDA, EMA) and international dermatology societies. | The SCORAD is a comprehensive clinician-administered tool for measuring the extent and severity of atopic dermatitis (eczema). Developed by the European Task Force on Atopic Dermatitis in 1993, it combines objective clinical assessment with subjective symptom reporting. It is the gold standard for atopic dermatitis severity in clinical trials and dermatology practice. |
| ScholarGateמערך נתונים ↗ |
|
|